Education
About Us
Working with TipRanks
Follow Us
Premier Inc (PINC)
NASDAQ:PINC
Tnx-1300 (Injection)
Cocaine Use, Cocaine Intoxication, Cocaine Toxicity, Cocaine Abuse, Cocaine Adverse Reaction
Phase II
Terminated
Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST)
Sep 13, 2023
―
Budesonide/Glycopyrrolate/Formoterol Fumarate (Breztri Aerosphere) 320 Μg/18 Μg/9.6 Μg Administered As Two Inhalations, Twice Daily., External Comparator
Copd
Phase IV
Withdrawn
IKANOS: Breztri Maintenance Versus Any Non-Triple Inhaled Therapy After Hospitalization for a COPD Exacerbation in the US
Jun 27, 2023
―
Tnx-1900
Chronic Migraine, Chronic Migraine, Headache, Chronic Migraine Without Aura, Aura Migraine
Phase II
Completed
A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine
Dec 19, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Premier Inc (PINC) have in its pipeline
PINC is currently developing the following drugs: Tnx-1300 (Injection), Budesonide/Glycopyrrolate/Formoterol Fumarate (Breztri Aerosphere) 320 Μg/18 Μg/9.6 Μg Administered As Two Inhalations, Twice Daily., External Comparator, Tnx-1900. These drug candidates are in various stages of clinical development as the company works toward FDA approval.